Sign In
Buy MDT
$77.95
+4.20 (+5.69%)
At Close: Jun 03, 2026
Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings
09:54am, Wednesday, 14'th May 2025
Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year, but now faces a pivotal earnings event on the 21st of May. Cardiovascular portfolio strength, especially fr
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:45pm, Thursday, 08'th May 2025
In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch
04:00pm, Thursday, 08'th May 2025
Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent mid-single-digit organic revenue growth.
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
06:07pm, Wednesday, 07'th May 2025
GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and ful
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
10:02am, Wednesday, 07'th May 2025
Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY,
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
09:45am, Saturday, 03'rd May 2025
Medical device specialist Medtronic (MDT 1.38%) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow revenue
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
06:50pm, Friday, 02'nd May 2025
Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.
Medtronic (MDT) Rises Higher Than Market: Key Facts
06:55pm, Wednesday, 30'th Apr 2025
Medtronic (MDT) concluded the recent trading session at $84.76, signifying a +0.19% move from its prior day's close.
Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized m
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
07:20pm, Saturday, 26'th Apr 2025
One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energ
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
02:32pm, Saturday, 26'th Apr 2025
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
02:20pm, Saturday, 26'th Apr 2025
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Associa
4 of Our Favorite Dividend Aristocrats Offer a Lifetime of Secure Passive Income
07:15am, Saturday, 26'th Apr 2025
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream and offer a promising avenue for total return.
Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: Late-b
The Smartest Dividend Stocks to Buy With $2,000 Right Now
03:09am, Friday, 25'th Apr 2025
Buying dividend stocks is always a smart plan. They have historically outperformed non-dividend payers by more than two-to-one (9.2% annualized return compared to 4.3% over the last 50 years, accordin
